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ABSTRACT 
Flaming, K., van der Maaten, M., Whetstone, C., Carpenter, S., Frank, D. and Roth, J., !993. Effect 
of bovine immunodeficiency-like virus infection on immune function in experimentally infected 
cattle. Vet.lmmunol.lmmunopathol., 36:91-105. 
Bovine immunodeficiency-like virus (BIV) is a bovine lentivirus that has antigenic and genetic 
homology with the human immunodeficiency virus. Little work has been reported on the effect of 
BIV infection on bovine immune function. This study was designed to evaluate lymphocyte blasto-
genesis, mononuclear cell subset numbers, neutrophil function, hematology, and clinical signs in three 
groups of cattle. These groups were evaluated at 0-2 months post inoculation (PI, Group I), 4-5 
months PI (Group 2), or 19-27 months PI (Group 3). BIV infected animals were inoculated with 
the R-29 isolate ofBIV in tissue culture cells, peripheral blood mononuclear cells from a R-29 infected 
calf, or a molecular clone of the R-29 isolate. Most inoculated animals seroconverted to BIV by West-
ern immunoblot. BIV was reisolated from most of the animals inoculated. BIV infection was associ-
ated with an increase in the lymphocyte blastogenic response to the mitogen phytohemagglutinin in 
Groups 2 and 3. Neutrophil antibody dependent cell mediated cytotoxicity and neutrophil iodination 
were decreased (P<0.05) in BIV infected cattle (Groups 2 and 3 and Group 3, respectively). All 
animals were clinically normal during the evaluation periods. Notable differences were not observed 
in the other assessments performed. Work with additional BIV isolates and over longer time frames 
is warranted. 
ABBREVIATIONS 
ADCC, antibody-dependent cell-mediated cytotoxicity; AICC, antibody-independent cell-me-
diated cytotoxicity; BIV, bovine immunodeficiency-like virus; BL V, bovine leukemia virus; Bo, bo-
vine; BSV, bovine syncytial virus; BVDV, bovine viral diarrhea virus; FBL, fetal bovine lung; HIV, 
human immunodeficiency virus; PBMC, peripheral blood mononuclear cells; PHA, 
phytohemagglutinin. 
Correspondence to: J. Roth, 2178 Veterinary Medicine, Iowa State University, Ames IA 50011, 
USA. 
© 1993 Elsevier Science Publishers B.V. All rights reserved 0165-2427/93/$06.00 
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INTRODUCTION 
Bovine immunodeficiency-like virus (BIV) is a bovine retrovirus of the 
lentivirus subfamily that was first isolated from a dairy cow, R-29, with per-
sistent lymphocytosis, progressive weakness and emaciation. At necropsy 
lymph node hyperplasia and lymphocytic perivascular cuffing in the brain 
were noted. Inoculation of calves with the R-29 isolate resulted in enlarge-
ment and follicular hyperplasia of lymph nodes as well as a transient lympho-
cytosis (Van der Maaten et al., 1972). In serologic surveys, conducted on 
approximately 2200 cattle in the southern USA, approximately 4% of the cat-
tle tested had antibody against BIV (Amborski et al., 1989; Black, 1990). BIV 
has structural and antigenic similarity to the human immunodeficiency virus 
(HIV). Western immunoblot analysis and indirect immunofluorescence test-
ing indicate shared antigenic epitopes of the gag (core) proteins of HIV and 
BIV. Sequence analysis of the 5' end of the BIV pol gene (which codes for 
reverse transcriptase) indicates 60% nucleotide sequence homology with other 
lentiviruses (HIV-1, equine infectious anemia virus,Visna virus, and caprine 
arthritis-encephalitis virus) (Gonda et al., 1987). 
The culmination of HIV infection is clinically apparent as the acquired im-
mune deficiency syndrome (AIDS). Yet, HIV infection does produce detect-
able changes in the host prior to the onset of AIDS. Infection with HIV has 
been associated with an acute 'flu-like' syndrome shortly after seroconversion 
(Cooper et al., 1985). A decrease in CD4 + lymphocytes and an increase in 
cos+ lymphocytes in the blood have been detected by 6 months after sera-
conversion to HIV (Giorgi et al., 1987; Giorgi and Detels, 1989). B cell an-
tibody production was reported to be compromised beginning at seroconver-
sion, while T cell proliferative responses remained normal during the first 10 
months (Terpstra et al., 1989 ). Other workers reported decreased lympho-
cyte blastogenic responses to mitogens in HIV infected individuals who were 
clinically staged at WR 1 (seropositive, clinically normal) with no estimate of 
the period ofinfection (Ridley et al., 1989). There have been few reports on 
the immunological effects of BIV infection in cattle. Interestingly, two calves 
were reported to have a selective depletion of CD4 + cells 3-4 months after 
inoculation with the original R-29 strain ofBIV (Stott et al., 1989). Infection 
with BIV was also associated with decreased blastogenesis to mitogens in two 
calves 6 months after infection (Martinet al., 1991 ) . Thus, there is evidence 
that measurable immune function changes following both HIV and BIV in-
fection are present within a relatively short period of time after infection. The 
present study was designed to evaluate the effect of BIV inoculation on sev-
eral measures of immune function in three groups of cattle at 0-2, 4-5, and 
19-27 months post inoculation (PI). These three groups were used to define 
an optimal challenge inoculum for BIV and to characterize early pathogenic 
effects of BIV infection. 
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MATERIALS AND METHODS 
Animals 
Group 1: animals 0-2 months PI 
Eight male Holstein calves, aged 2-4 months, were randomly assigned to 
either control ( n = 3) or BIV ( n = 5) inoculated groups. The control and in-
oculated calves were housed in separate rooms inside isolation facilities at the 
Veterinary Medical Research Institute, Ames, lA. All of the animals were 
tested on Days - 24 and 60 for antibodies to bovine syncytial virus ( BSV), 
and bovine leukemia virus (BLV) by agar gel immunodiffusion (Malmquist 
et al., 1969; Miller and Vander Maaten 1976 ), and to BIV by Western blot 
analysis (Whetstone et al., 1991). Two animals appeared to have maternal 
antibodies to BLV or BSV. These animals were weakly positive when initially 
tested, but 85 days later the same animals were negative for both viruses. All 
of the calves were seronegative for BIV before inoculation and were seroneg-
ative for BLV and BSV at 60 days PI. Of the five BIV inoculated animals, 
only three developed antibody against BIV. The results presented are from 
only the three BIV antibody positive animals. 
Inoculum for Group 1 animals 
Cell culture material infected with BIV, isolate R-29, was inoculated into a 
Holstein calf aged < 3 months. The BIV was then serially passed through three 
more calves by directly transfusing blood from an infected calf to a non-in-
fected calf as previously described (Carpenter et al., 1992). This serial pas-
sage was done in an attempt to increase the virulence of the R-29 isolate and 
to obtain a challenge inoculum that was free of bovine viral diarrhea virus 
(BVDV), which is known to contaminate the R-29 isolate. Peripheral blood 
mononuclear cells ( PBMC) from the last infected calf were isolated by den-
<>ity gradient centrifugation, resuspended in a solution containing 81% Eagle's 
minimum essential-medium, 9% fetal bovine serum, and 10% dimethyl sulf-
oxide at a concentration of 2. 5 X 105 cells ml- 1• The cells were frozen in a 
stepwise fashion: 12 hat -20°C, 24 hat - 70°C, and then stored in liquid 
nitrogen. The inoculum produced BIV syncytia in cell culture, but did not 
contain BVDV when tested by indirect immunofluorescence assay. The fro-
zen inoculum was rapidly thawed immediately prior to intravenous inocula-
tion into the calves. Each ofthe five calves in the BIV group received 2.5 X 107 
PBMC intravenously on Day 0 of the experiment. Control animals received 
a like number of similarly treated cells from a BIV negative animal. 
Sample collection for Group 1 animals 
Blood was collected two to three times a week for hematologic evaluation 
during Weeks -3 through 10. Blood (250 ml) was collected twice per week 
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in Weeks - 1 to 8, for in vitro immune function analysis (described below). 
Mononuclear cell subset analysis and virus isolation were performed once a 
week. The animals were observed daily, and rectal temperatures were re-
corded three times a week. 
Group 2: animals 4-5 months PI 
Nine male Holstein calves, 2-4 months old, were randomly assigned to 
either control (five animals) or BIV inoculated (four animals) groups. All 
animals were free of antibody to BIV (Western blot analysis), and BLV (agar 
gel immunodiffusion) at the beginning of the experiment. All of the animals 
but one BIV infected calf were free of antibody to BSV. The animals were 
housed together by group with the groups physically separated. 
Inoculum for Group 2 animals 
The four BIV inoculated animals received fetal bovine lung ( FBL) cell cul-
ture material that contained 1.8X 104 syncytium forming units ofBIV R-29. 
Because this culture material was contaminated with a non-cytopathic strain 
of BVDV, all animals were vaccinated with a commercial killed BVDV vac-
cine 4 and 2 weeks prior to inoculation. Control animals received FBL cells 
and were infected with a non-cytopathic BVDV. (Field isolate of a non-cyto-
phatic BVDV from persistently infected cattle in Nebraska obtained from S.R. 
Bolin, NADC, Ames, lA) 
Sample collection for Group 2 animals 
Animals were evaluated twice during 1 week at both 4 and 5 months PI for 
total and differential white blood cell count, neutrophil function, mononu-
clear cell subset analysis, and lymphocyte blastogenesis. 
Group 3: animals 19-27 months PI 
Eight cattle that had been infected with BIV for a period of 19-27 months 
were used in this experiment. Table 1 indicates the details of the individual 
animals. The seven (four female, three male) control cattle were 2-5 years of 
age, and were either Holstein, Holstein/ Angus cross-bred, or Charolais/ An-
gus cross-bred. All animals had no detectable antibody to BSV or BLV (agar 
gel immunodiffusion). Control animals were free of BIV specific antibodies. 
All BIV infected animals were negative for antibodies to BIV prior to 
inoculation. 
Inocula for Group 3 animals 
The BIV infected animals received different inocula as described in Table 
1. The BIV-106 molecular clone (provided by M.A. Gonda, Laboratory of 
Cell and Molecular Structure, Program Resources, Inc., NCI-Frederick Can-
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cer Research Facility, Frederick, MD) of the virus was derived from the orig-
inal R-29 isolate of BIV (Braun et al., 1988; Garvey et al., 1990). Control 
animals received no inoculation. 
Sample collection for Group 3 animals 
All animals were tested at least twice during a 3 week period for total and 
differential white blood cell count, neutrophil function, and lymphocyte blas-
togenesis. Mononuclear cell subset analysis was performed once for each 
animal. 
Methods 
In vitro immune function 
Blood (250 ml) was collected by jugular venipuncture into acid citrate/ 
dextrose anticoagulant. After centrifugation, plasma was discarded and the 
buffy coat was removed for mononuclear cell isolation by density gradient 
centrifugation, as previously described (Roth et al., 1982 ). Neutrophils were 
isolated from the packed red blood cells ( RBC), by hypotonic lysis of the 
RBC as previously described (Roth and Kaeberle, 1981 b). Isolated neutro-
phils were suspended in 0.015 M phosphate-buffered saline solution ( PBSS) 
at a concentration of 5.0 X 107 cells ml- 1 for use in the functional assays. 
Neutrophil function assays were performed as described previously (Roth 
and Kaeberle, 1981 b; Steinbeck et al., 1986; Chiang et al., 1991). Briefly, 
random migration under agarose was measured after an incubation period of 
18 h; the area of random migration was reported in mm2• Chemotaxis was 
measured by migration under agarose toward zymosan-activated serum; the 
chemotactic index was determined by dividing the distance of directed migra-
tion by the distance of random migration. Phagocytosis was measured using 
antibody-coated [ 125I]iododeoxyuridine-labeled Staphylococcus aureus. 
N eutrophils were incubated for 10 min with bacteria at a ratio of 60: 1 ( bac-
teria to neutrophil), then lysostaphin was added to remove the extracellular 
S. aureus; results were reported as percentage of bacteria ingested. Reduction 
of cytochrome c, a measure of superoxide anion production, was evaluated 
after a 30 min (Group 1 ) or a 5 min (Groups 2 and 3) incubation of neutro-
phils with cytochrome c and opsonized zymosan. Results were reported as 
optical density per 1.25 X 106 neutrophils per 5 or 30 min. The iodination 
reaction, a measure of the myeloperoxidase-H20 2-halide system, was mea-
sured by incubating neutrophils with opsonized zymosan and Na125l for 20 
min; the reaction was terminated by addition of trichloroacetic acid. Results 
were reported as nmol Nal 1 o- 7 neutrophils h- 1• Antibody-dependent cell-
mediated cytotoxicity (ADCC) was evaluated using antibody-coated 51 Cr-
labeled chicken RBC as the target cell. The effector-to-target cell ratio was 
10: 1, and results were reported as percentage of specific release during a 2 h 
incubation. Antibody-independent cell-mediated cytotoxicity (AICC) was 
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measured similarly to ADCC; however, antibody was not added. Lymphocyte 
blastogenesis was performed using pokeweed mitogen, phytohemagglutinin 
(PHA), and concanavalin A as mitogens, with a 60 h incubation period as 
described by Roth et al. ( 1982). Mitogens were used at concentrations that 
resulted in optimal stimulation of lymphocytes from control cattle. 
Antibodies for mononuclear cell subset analysis 
Primary antibodies were purchased from VMRD (Pullman, W A). The hy-
bridoma designation for each antibody follows the cell type the antibody was 
used to detect (Bo indicates bovine): BoCD4, CACT83B; BoCD8, CACT80C; 
BoCD2, CH128A; BoCD6, BAQ82A; B-cells, BAQ44A; monocytes, DH59B; 
null (non-T, non-B, non-monocyte) cells, BAQ4A (Davis et al., 1987, 1988, 
1991; Larsen et al., 1990). Murine monoclonal antibodies against non-lym-
phocyte antigens were used as isotype controls. The fluorescein isothiocyan-
ate (FITC)-conjugated goat anti-mouse IgG-IgM second antibody was ob-
tained from Cal tag Laboratories (South San Francisco, CA). 
Mononuclear cell subset analysis by flow cytometry 
Isolated PBMC were suspended in PBSS containing 0.5% bovine serum 
albumin and 0.1% NaN 3 ( PBSS + + ) at a concentration of 5 X 106 cells ml- 1. 
Then 200 J.tl of cells were added to aU-bottom microtiter plate. The plate was 
then centrifuged for 60 s at 160 X g. The supernatant was discarded and the 
cells were resuspended in 50 ,ul of the appropriate antibody, diluted 1 : 100 in 
PBSS + +. The plate was incubated for 30 min on ice, then washed three times 
using PBSS + +. A second 30 min incubation was performed in 50 ,ul of the 
1 : 100 diluted FITC-conjugate. The cells were washed three times, resus-
pended, and fixed by the addition of 200 ,ul of a 1 : 1 mixture of PBSS and 2% 
paraformaldehyde in water. The plate was stored at 4 oc, in the dark, until 
flow cytometric analysis was performed 1-5 days later. 
Flow cytometry 
A Coulter Epics 752 flow cytometer was used for data collection. Forward 
and right-angle light scatter as well as fluorescein fluorescence were mea-
sured. Gating, using forward and right-angle light scatter, was set such that 
any contaminating RBC or granulocytes were excluded from the analysis. Be-
cause of substantial overlap in the monocyte and lymphocyte populations the 
analysis was performed using the whole mononuclear cell population. Dis-
criminators were set using the second antibody control for each animal so that 
background fluorescence was always less than 5% (2% for the 4-5 and 19-27 
month PI data) of the cells surveyed. For each sample, 5000 cells were 
analyzed. 
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Hematology 
Blood samples for hematologic evaluation were collected in evacuated blood 
collection tubes containing sodium EDTA. Hemoglobin concentrations were 
measured by optical density. Total leukocyte counts were made using an elec-
tronic particle counter. Differential leukocyte determinations were made by 
examining 200 leukocytes on Wright-stained blood smears. 
Serology and virus isolation 
Western blot analysis and virus isolations by cocultivation with FBL cells 
were performed as previously reported (Whetstone et al., 1990, 1991 ). The 
ELISA titers reported for BIV are from an ELISA that detects antibody to the 
whole virus (Whetstone, 1992). The virus is grown as previously described 
(Whetstone et al., 1991 ) . Plates are coated with antigen (virus) in carbonate 
buffer, pH 9.6, and blocked with 0.1% bovine serum albumin +0.2% Tween 
20. Washes are carried out with 0.02% Tween 20 in 0.01M PBS pH 7.4. Neg-
ative control sera were negative at a 1 : 10 dilution. 
Statistical analysis 
The neutrophil function, lymphocyte blastogenesis, mononuclear cell sub-
set, and hematology data were analyzed by week of the experiment using a 
repeated measures analysis of variance as appropriate for the Group 1 data. 
The data from Group 2 were analyzed using a repeated measures analysis of 
variance. Similarly, the data from Group 3 were analyzed using a repeated 
measures analysis of variance including a blocking factor for the date of assay, 
since all animals were not assayed on the same day. A simple analysis of var-
iance blocking on assay day was used for the mononuclear cell subset data of 
the 19-27 month PI animals. 
RESULTS 
Virus recovery and antibody response 
All BIV inoculated animals developed BIV specific antibodies that were 
detectable by Western blot analysis, except that two of the five inoculated 
animals in Group 1 did not seroconvert. The data reported for Group 1 is 
from the three antibody positive BIV inoculated animals. Virus was re-
covered from one of these three animals in Group 1 at 60 days PI. BIV was 
reisolated from all animals in Group 2 at both 4 and 6 months Pl. ELISA 
titers to BIV were 1 : 150 for all four animals in Group 2 at the time of im-
mune function testing. In Group 3 BIV was recovered from three of eight 
animals. Virus recovery was not attempted on one animal, and recovery was 
unsuccessful from the other four animals in Group 3 (Table 1 ) . Titers to BIV 
by ELISA were 1 :50 or 1 : 100 for all Group 3 animals (Table 1). 
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TABLE I 
Characteristics of the cattle infected with BIV for 19-27 months 
Animal Sex Breed BIV inoculation Age at Age at BIV BIV 
inoculation leukocyte isolation ELISA 
evaluation titer 
246 M Jersey R29 cell culture. IV 1 10 months 37 months + I: 50 
1029 F Holstein/ Angus R29 whole blood, fourth 5 weeks 20 months NO I: 100 
passage, IV 
1034 F Holstein/ Angus BIV-106 clone cell 6 hours 23 months + 1:50 
culture, IV 
1049 M Angus R29 cell culture, IV 8 months 29 months - I: 100 
1060 M Holstein/ Angus R29 whole blood, second 3 weeks 21 months + I :50 
passage, IV 
1187 F Holstein BIV -I 06 clone cell 3 months 26 months - I: 100 
culture, intracisternal 
1188 F Holstein BIV-106 clone cell 3 months 26 months - I: 50 
culture, intracisternal 
1476 F Angus/Hereford BIV-106 clone cell 3 months 26 months - I: 100 
culture, intracisternal 
All cattle developed antibodies specific for BIV antigens after inoculation as detected by Western blot 
analysis. They had no detectable antibodies to either bovine leukemia virus or bovine syncytial virus. 
1IV, intravenous. 
Clinical signs and hematology 
All animals were clinically normal during the period of evaluation. There 
were no significant ( P < 0.05) differences noted in rectal temperatures or other 
clinical signs between control and BIV infected animals. The only hemato-
logic measure (hemoglobin, total and differential leukocyte count) that was 
significantly different between control and BIV infected animals was that BIV 
infected animals at 19-27 months PI had greater total leukocyte counts as a 
result of an increase in neutrophils (P<0.05; BIV, 3040 neutrophils ,ul-'; 
control, 1980 neutrophils ,ul- 1 ). 
Mononuclear cell subset analysis 
Based on the previous reports of lymphoproliferation and alteration in T 
cell subsets following BIV infection, we were interested in evaluating mono-
nuclear cell subset populations during these experiments. The only difference 
observed between BIV and control animals was an increase in the percentage 
of blood mononuclear cells identified as null cells in Group 3 animals (Table 
2 ). Null cell populations at 0-2 and 4-5 months PI were similar in BIV and 
control groups. The importance of the change in null cell populations is ques-
tionable since it only occurred in one group. Table 2 represents 60 compari-
sons of which one would expect to find three significant at the P<0.05level 
by random chance. There were no differences in the percentages of cells iden-
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TABLE2 
Percentage ofPBMC for BIV infected and control cattle 
Cell 0-2 months PI' 4-5 months PI 19-27 months PI 
BIV Control BIV Control Pr>F BIV Control Pr>F 
(n=3) (n=3) (n=4) (n= 5) (n=8) (n=7) 
BoCD4 24 24 24 24 0.84 25 26 0.93 
BoCD8 II 12 12 II 0.49 12 15 0.34 
BoCD2/CD6 33 34 34 33 0.82 36 38 0.77 
(Pan T) 2 
Null 15 13 16 15 0.75 15 9 0.03 
Monocyte 17 16 23 20 0.58 15 14 0.74 
B-cell 27 27 20 25 0.16 25 28 0.74 
Bo, bovine; Pr> F: the probability of having a greater F value for the comparison of BIV to control 
groups simply by chance. n is number of animals per group. 
'The means presented for the 0-2 month data are the mean for each treatment over all assay days. 
Data were analyzed weekly for 8 weeks post inoculation; hence no Pr> F is appropriate for these 
means. No consistent significant differences were found between BIV and control animals. Occa-
sional differences at P<0.05 did occur but the differences were not consistent and occurred at a fre-
quency ofless than one in 20 comparisons. 
2BoCD6 was used for the 0-2 month experiment (CD6 is expressed on most T-cells and on some B-
cells). BoCD2 was used for the other two experiments (a Pan T marker). 
TABLE 3 
Lymphocyte blastogenic response to mitogens for control and BIV infected cattle 
Mitogen 0-2 months PI' 4-5 months PI 19-27 months PI 
BIV Control BIV Control Pr>F BIV Control Pr>F 
(n= 3) (n=3) (n=4) (n= 5) (n=8) (n=7) 
Phytohemagglutinin 45700 29200 17900 8700 0.03 26100 11900 0.06 
( Lf counts min- 1 ) 
Concanavalin A 21700 19800 17000 9400 0.24 24900 14000 0.15 
( Lf counts min- 1 ) 
Pokeweed mitogen 19000 29500 5800 2400 0.34 4800 3600 0.18 
( Lf counts min- 1 ) 
Unstimulated 700 500 700 700 0.92 600 320 0.11 
(counts min- 1 ) 
Pr> F: the probability of having a greater Fvalue for the comparison ofBIV to control groups simply 
by chance. Lf counts min- 1 is difference in counts min- 1 (counts min- 1 with mitogen- unstimulated 
counts min_,). n is number of animals per group. 
'The means presented for the 0-2 month data are the mean for each treatment over all assay days. 
Data were analyzed weekly for 8 weeks post inoculation; hence no Pr> F is appropriate for these 
means. No consistent significant differences were found between BIV and control animals. Occa-
sional differences at P<0.05 did occur but the differences were not consistent and occurred at a fre-
quency ofless than one in 20 comparisons. 
100 K. FLAMING ET AL. 
TABLE4 
Neutrophil function in BIV infected and control cattle 
Test 0-2 months Pl 1 4-5 months PI 19-27 months PI 
BIV Control BIV Control Pr>F BIV Control Pr>f 
(n=3) (n=3) (r,=4) (n= 5) (n=8) (n=7) 
Random migration 39 42 33 38 0.24 28 33 0.28 
(mm2 ) 
Chemotaxis 1.58 1.47 1.48 1.52 0.63 1.54 1.63 0.58 
(directed/random) 
S. au reus ingestion (%) 25 24 36 35 0.63 47 44 0.42 
Iodination ( nmol Nal JQ- 7 22 20 33 32 0.52 38 52 0.02 
PMNh- 1 ) 
Cytochrome c reduction 0.65 0.62 0.75 0.82 0.17 0.95 0.96 0.83 
(OD) 
AICC 5.8 12.6 3.3 6.1 0.03 2.8 3.5 0.69 
(% specific lysis) 
ADCC 48 53 38 53 0.01 38 53 0.02 
( OJo specific lysis) 
Pr > F: the probability of having a greater F value for the comparison of BIV to control groups simply 
by chance. n is number of animals per group. 
1The means presented for the 0-2 month data are the mean for each treatment over all assay days. 
Data were analyzed weekly for 8 weeks post inoculation; hence no Pr> F is appropriate for these 
means. No consistent significant differences were found between BIV and control animals. Occa-
sional differences at P < 0.05 did occur but the differences were not consistent and occurred at a fre-
quency ofless than one in 20 comparisons. 
tified as monocytes, B cells, CD2 + cells, CD4 + cells, or CD8 + cells in any of 
the groups tested (Table 2). Comparisons of the actual number of cells in 
each subset yielded similar conclusions. 
Lymphocyte blastogenesis and neutrophil function 
The results of the lymphocyte blastogenesis assays indicated a tendency for 
BIV to increase the blastogenic response to mitogens. In eight of nine com-
parisons the mean response of BIV infected animals was greater than control 
animals (Table 3). The response to PHA was significantly higher at 4-5 
months PI (P<0.05) andnearlysoagainat 19-27monthsPI (P<0.06). The 
response to the other mitogens tested was not significantly altered by BIV 
infection. Neutrophil ADCC and AICC were both decreased (P<0.05) at 4-
5 months PI. Iodination and ADCC were also decreased in the BIV infected 
animals at 19-27 months PI (P<0.03). Other measures of neutrophil func-
tion were not affected by BIV infection (Table 4). 
Because of the nature of lentiviral infections, the disease course may be 
expected to differ in different animals. Therefore, in addition to the statistical 
analyses comparing groups of animals, the raw data were examined to deter-
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mine if any individual animal or subset of animals deviated notably from 
normal in any of the various measures. None of the individual animals had 
any measures which markedly and consistently varied from normal. We also 
found no differences in Groups 1 and 3 when comparing animals that virus 
had been recovered from, with those that virus had not been recovered from. 
DISCUSSION 
Taken collectively, these data indicate that BIV infection is capable of in-
ducing alterations in the bovine immune system. Initially, no alterations were 
observed in animals tested three times a week for the first 2 months following 
infection. However, at 4-5 months PI neutrophil ADCC and AICC were sig-
nificantly decreased while lymphocyte blastogenesis to. PHA was increased. 
At 19-27 months PI, neutrophil iodination, a measure of degranulation and 
oxidative metabolism, was decreased in addition to the decrease in ADCC. 
Lymphocyte blastogenesis to PHA was higher in BIV infected animals 19-27 
months PI. The fact that decreased ADCC and increased blastogenesis to PHA 
were recorded in two separate groups of BIV infected animals adds to the 
significance of these observations. The increase in blastogenesis to PHA is 
consistent with the previous observations that BIV infection causes lymphoid 
proliferation rather than lymphoid depletion in infected cattle (Vander Maa-
ten et al., 1972; Carpenter et al., 1992). 
Our observations differ from the previously reported decreases in lympho-
cyte blastogenesis (Terpstra et al., 1989) and in CD4 cell numbers (Stott et 
al., 1989) following BIV infection. Differences in inocula, concurrent infec-
tions, and individual animal variation may have contributed to the contrast-
ing observations. The reported decrease in lymphocyte blastogenesis was ob-
served at 6 months PI in two animals that were tested 2 and 6 months PI 
(Terpstra et al., 1989). We observed an increase in lymphocyte blastogenesis 
at 4-5 months PI and 19-27 months PI. The previously reported decrease in 
CD4 cells occurred at 3-4 months after infection (Stott et al., 1989). Similar 
to our experiment, the calves in the previous reports were challenged with 
high passage BIV R-29 infected cell culture material that contained BVDV. 
Lymphoid depletion has been reported to follow lymphoproliferation in HIV 
and simian immunodeficiency virus infection (Chalifoux et al., 1987; Ger-
stoft et al., 1989; Ost et al., 1989). The decreased blastogenesis and drop in 
CD4 + cells may be a transient event which we did not detect. 
The R-29 isolate is the only reported isolate of BIV. However, this isolate 
of BIV had been passed multiple times in tissue culture, and it may have be-
come tissue culture adapted, losing some of its original virulence. In addition, 
all available cultures of the R-29 virus were also co-infected with a non-cyto-
pathic strain of BVDV. The BVDV is known to induce neutropenia and lym-
phopenia, and to impair neutrophil and lymphocyte function during the first 
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month after infection (Tyler and Ramsay, 1965; Malmquist, 1968; Roth et 
al., 1981, 1986). In an attempt to increase the virulence and to obtain a chal-
lenge inoculum which was free of BVDV the R-29 isolate was serially passed 
through calves. The serial passage did succeed in eliminating the co-infecting 
BVDV, but apparently did not restore the R-29 isolate to its original virulence 
(Carpenter et al., 1992). The inoculum given to the Group 1 animals appears 
to have been a minimal dose for BIV infection: only three of five serocon-
verted and virus was recovered from only one animal. Possibly, some virus 
viability was lost during the preparation and storage of the frozen inoculum 
used for this experiment. The lack of any immune function alterations ob-
served in this group may have been the result of the low virulence of the in-
oculum rather than the inability of BIV to cause such changes. A different 
method for preparing the inoculum for the Group 2 animals was used in an 
attempt to establish a more consistent infection. Immune function was not 
evaluated in Group 2 animals until 4 months after infection to ensure that 
the BVDV present in the inoculum had been cleared by the animals. The R-
29 virus, grown to a high titer in FBL cell cultures, proved to be a good chal-
lenge inoculum since all Group 2 animals produced antibody, and BIV could 
be successfully recovered from them. 
BIV infection did not cause any clinical signs of disease in these animals. 
Therefore, the biological significance of the recorded alterations in immune 
function are not clear. Yet, similar decreases in ADCC and iodination have 
been observed in BVDV infected cattle and cattle treated with dexametha-
sone (Roth and Kaeberle, 198la, 1984, 1985; Roth et al., 1981, 1986; Roth 
and Frank, 1989). Both BVDV infection and dexamethasone treatment have 
been associated with increased disease incidence. Neutrophil ADCC is thought 
to be an important antiviral mechanism for cattle. The myeloperoxidase-
H202-halide system, measured by the iodination assay, is a potent bacterio-
cidal mechanism of the neutrophil. A defect in this system may lead to in-
creased susceptibility to bacterial infection. The animals in this study were 
housed in isolated groups and were not exposed to animals with clinically 
significant bacterial infections. 
The e.ffe-£t of BIV may bee-erne more -mar-ked as the time after infection 
increases. This pattern would be similar to other mammalian lentiviruses. 
Recent studies have indicated changes in T-cell subsets were detectable in 
feline immunodeficiency virus infected cats at 6 months post infection; defi-
cits in proliferative responses to mitogens were progressive beginning at 6 
months post infection (Torten et al., 1991 ). During HIV infection, changes 
in T -cell subsets are evident by 6 months after the first detection of serum 
antibody to HIV (Giorgi and Detels, 1989); however, clinical disease is often 
not apparent for years. Ovine lentivirus infection usually occurs by colostral 
transmission shortly after birth, but the pneumonia associated with Maedi/ 
Visna is usually not observed until the animal is 2-3 years of age (Cutlip et 
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al., 1988 ). In a like manner, the disease associated with caprine arthritis-
encephalitis virus may take months or years to develop (Cheevers and 
McGuire, 1988). In contrast, the equine infectious anemia virus may induce 
clinical disease within several days after infection (Cheevers and McGuire, 
1988 ). 
BIV infection does appear to cause alterations in bovine lymphocyte and 
neutrophil function by 4-5 months after infection. Current inocula do not 
cause the degree of lymphocytosis induced by the original isolate. Following 
infected animals for a longer time after infection and work with additional 
isolates are needed to further define the potential significance of BIV infec-
tion on the bovine immune system. 
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